Jan 9, 2013 by Dan CarrollChina Slashing Prices of Hundreds of DrugsCuts to affect Pfizer, Merck, and others in fourth such price cut since 2011.
Jan 8, 2013 by Dan CarrollEarnings Season Keeps Pressure on the DowThe index falls sharply again with Alcoa set to report.
Jan 8, 2013 by Dan CarrollThe 4 Worst Overseas Markets of 2012Which international markets wasted your money last year?
Jan 8, 2013 by Dan CarrollQualcomm Introduces Newest Snapdragon ProcessorsNew chips offer up to 75% better performance over prior generation.
Jan 8, 2013 by Dan CarrollLampert to Assume CEO Role at Sears HoldingsLouis D'Ambrosio steps down for "family health matters."
Jan 7, 2013 by Dan CarrollGilead, MacroGenics Ink Antibody Licensing DealDeal could be worth in excess of $1 billion to MacroGenics.
Jan 7, 2013 by Dan CarrollFDA Approves Abbott's Next-Generation StentCompany will pursue immediate U.S. rollout of Xience Xpedition drug-eluting stent.
Jan 7, 2013 by Dan CarrollHologic Selling Lifecodes Business to ImmucorHologic records sale for up to $95 million.
Jan 7, 2013 by Dan CarrollThe Dow Falls on the Day Before Earnings KickoffAlcoa reports tomorrow, but the Dow's sinking into the red today.
Jan 7, 2013 by Dan CarrollThe 5 Best Overseas Markets of 2012Which overseas markets rewarded your investing dollars last year?
Jan 4, 2013 by Dan CarrollToday's Deceptive Rally in Dry Bulk ShippingDon't get caught up in the latest short-term surge
Jan 4, 2013 by Dan CarrollA&E Content Coming to Amazon Prime Instant VideoMove brings A&E, History, Lifetime, and more content to instant video service.
Jan 4, 2013 by Dan CarrollThe Dow Ends a Great Week With GainsAfter Wednesday's rally, stocks continue to climb
Jan 3, 2013 by Dan CarrollWhy the Dow's Sitting Flat After Yesterday's RallyFederal Reserve minutes erase the index's modest gains.
Jan 2, 2013 by Dan CarrollThe Future Arrives for Abbott LabsOn the first day of the new Abbott, what should you watch for this revamped company's future?
Jan 2, 2013 by Dan CarrollWhy the Dow's Overreacting to the Fiscal-Cliff DealTriple-digit gains may make investors happy, but the drama from Washington is nowhere near over.
Jan 2, 2013 by Dan CarrollFDA Approves Salix Pharmaceuticals' Fulyzaq for HIV/AIDS PatientsAnti-diarrhea drug for HIV/AIDS patients is first of its kind.
Jan 2, 2013 by Dan CarrollISM: Manufacturing Sector ExpandsOverall economy grew for 43rd consecutive month.
Jan 2, 2013 by Dan CarrollCharting the Future of HIV in 2012Last year showed revolutionary breakthrough and rising revenues in fighting HIV/AIDS.
Dec 31, 2012 by Dan CarrollFiscal Cliff Hopes Spur the Dow's GainsMost stocks rising on final day of the year
